In an initial study, 11 patients with relapsed refractory non-small cell lung cancer (NSCLC) in which >50% tumour cells were EGFR+ were infused with up to 2.5 × 107 CAR T-cells/kg [34]. Here, EGFR is linked to neoplasm.